News
The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...
1h
WRIC ABC 8News on MSNUVA researchers warn GLP-1 drugs may not provide long-term weight loss benefitsNew research from experts at the University of Virginia (UVA) says that GLP-1 drugs may help people lose weight, but do not ...
1h
HealthDay on MSNRisk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, ObesityFor adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...
Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...
The world of prior authorization, and the hoops we need to jump through, has gotten just more and more ridiculous, bordering ...
A WOMAN who lost a staggering five stone thanks to weight-loss jabs has hit back at trolls who brand her an “Ozempic cheat”.
With 700 challenger brands competing for attention, those offering functional benefits - particularly gut health - dominated the event as entrepreneurs raced to catch the eye of supermarket buyers and ...
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
In today's Morning Rounds newsletter: a failed long Covid drug may get another shot, the benefits of even a little activity ...
West Pharmaceutical Services Inc. (NYSE: WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays ...
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results